MENU
RCUS
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Arcus Biosciences (RCUS) Ownership - Who owns Arcus Biosciences?

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company... Show more

Profile

Industry
Pharmaceuticals Major
Address
3928 Point Eden Way
Phone
+1 510 694-6200
Employees
577
Web
https://www.arcusbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
955.08M
P/E Ratio
N/A
Total Cash
997M
Projected Growth
N/A
Total Debt
60M
Revenue
141M
Risk (Beta)
0.95
Dividend Yield
N/A
Total Cash/Share
9.42
Total Debt/Equity
N/A
Revenue/Share
1.51 USD as % of share price

Fundamentals

RCUS
Capitalization
955M
P/E Ratio
N/A
Risk (Beta)
0.95
Dividend Yield
N/A
Total Cash
997M
Total Cash/Share
9.42
Total Debt
60M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.51%
Revenue
141M
ROE
N/A
Book Value
531M
P/B Ratio
1.80
Cash Flow
N/A
Earnings
-4.23
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.78B
Current Ratio
5.37
Current Revenue Per Employee
41543.03
Dividends Per Share - Security
N/A
EBITDA
-377M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-31.93
Shares Held By Institutions
1.09B
Shares Outstanding - Current
106M
Total Liabilities
625M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-39.422
View a ticker or compare two or three
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company which offers pre-clinical drug discovery and development solutions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
3928 Point Eden Way
Phone
+1 510 694-6200
Employees
577
Web
https://www.arcusbio.com